Based on the provided data, here's a concise analysis of SRAD's valuation:
SRAD shows improving fundamentals with revenue growth of 20.2% from €730.2M (2022) to €877.6M (2023), while net income tripled from €10.9M to €34.7M. The company's valuation metrics have become more attractive, with P/E ratio dropping significantly from 267x to 89.7x, and EV/EBITDA declining from 12.1x to 9.7x.
The stock is currently trading at $21.26, near its 20-day SMA of $21.48, with RSI-14 at 54.56 indicating neutral momentum. Recent analyst coverage is bullish, with Citi raising the price target to $25 from $20 and Craig-Hallum maintaining a $40 target.
Given the improving fundamentals, reasonable valuation multiples compared to historical levels, and strong analyst support, SRAD appears fairly valued at current levels with potential upside based on continued execution and sports betting market growth.